Video

Dr Elaine Fuchs Explains How Stem Cell Discoveries Fuel Cancer Therapeutics

Isolating and comparing cancer stem cells with their normal counterparts has allowed researchers to identify hundreds of differences that can be used to target therapies, said Elaine Fuchs, PhD, an investigator at the Howard Hughes Medical Institute at the Rockefeller University.

Isolating and comparing cancer stem cells with their normal counterparts has allowed researchers to identify hundreds of differences that can be used to target therapies, Elaine Fuchs, PhD, an investigator at the Howard Hughes Medical Institute at the Rockefeller University, said at the 56th ASH Annual Meeting in San Francisco, December 6-9, 2014.

“Then the question was: ‘What can we do with those differences?’” she said.

Now that they know how stem cells behave, they can understand how cancer stem cells communicate differently with their environment and identify which of the hundred of changes are fueling the cancer.

Related Videos
Screenshot of an interview with Evangelia Vlachou, MD
Screenshot of an interview with Barry Goy, MD
Debra Patt, MD, PhD, MBA, MPH
Clayton Irvine, PharmD, MBA, MS.
Debra Patt, MD, PhD, MBA, MPH
Debra Patt, MD, PhD, MBA, MPH
Chelsee Jensen, PharmD, BCPS.
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Sandra Cuellar, PharmD
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo